FDA Drug Recalls

Recalls / Class II

Class IID-1385-2019

Product

Bisacodyl Suppositories, Brite Stock, Reese.

Affected lot / code info
Lot #s: 17J003, Exp. 09/2019; 18A026, Exp. 01/2020; 18E031, Exp. 05/2020.

Why it was recalled

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Recalling firm

Firm
Torrent Pharma Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2091 Hartel Ave, N/A, Levittown, Pennsylvania 19057-4506

Distribution

Quantity
N/A
Distribution pattern
Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.

Timeline

Recall initiated
2019-05-21
FDA classified
2019-06-13
Posted by FDA
2019-06-19
Terminated
2020-10-06
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1385-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.